Japan Tissue Engineering Co Ltd Sustainability Reports
The company commercializes and manufactures regenerative medicine products, such as autologous cultured epidermis and cartilage. It also provides contract development and manufacturing services (CDMO) for cell and gene therapies.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
FIGI: BBG001T0RYH3
1 reports from 2026 to 2026
